LAURAN NEERGAARD | RedHillsMSNews.com

Home

In this image provided by the Serum Institute of India, vials of freshly manufactured Novavax COVID-19 vaccines wait to be labeled in 2022, in Pune, India. The more traditional kind of COVID-19 vaccine moved a step closer to the U.S. market Tuesday, June 7, 2022. Advisers to the Food and Drug Administration voted to back shots made by Novavax for U.S. adults. If the FDA ultimately agrees, Novavax's option could become the nation's fourth COVID-19 vaccine. (Serum Institute of India for Novavax via AP, File)

AP
premium content - for subscribers only
Click to subscribe

FDA advisers back Novavax COVID shots as 4th US option
By LAURAN NEERGAARD - AP Medical Writer
Tue,06/07/22-2:42PM , 166 Reads
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.
Click Here to Read More

Novovax COVID-19 vaccine's incubate in flasks at the company research laboratory in Gaithersburg, Md., on May 24, 2022. The company is hoping to find a niche among some of the unvaccinated millions who might agree to their more traditional protein vaccine as a shot. (AP Photo/Angie Wang)

AP
free content

Novavax hopes its COVID shot wins over FDA, vaccine holdouts
By LAURAN NEERGAARD - AP Medical Writer
Thu,06/02/22-11:31AM , 144 Reads
GAITHERSBURG, Md. (AP) — Americans may soon get a new COVID-19 vaccine option -- shots made with a more tried-and-true technology than today’s versions. The big question: Why should they care?
Click Here to Read More

This photo provided by the Providence Cancer Institute of Oregon in May 2022 shows Kathy Wilkes of Ormond Beach, Fla. Wilkes, with advanced pancreatic cancer, saw her tumors dramatically shrink after researchers in Oregon turbocharged her own immune cells, highlighting a possible new way to someday treat a variety of cancers. (Providence Cancer Institute of Oregon via AP)

AP
registered content - login required to view
Click to register / login

Novel genetic experiment shrinks tough-to-treat cancer
By LAURAN NEERGAARD - AP Medical Writer
Wed,06/01/22-4:00PM , 178 Reads
In a novel experiment, a woman with advanced pancreatic cancer saw her tumors dramatically shrink after researchers in Oregon turbocharged her own immune cells, highlighting a possible new way to someday treat a variety of cancers.
Click Here to Read More

Syringes and colorful bandages are prepared as children from local schools prepare to get COVID-19 vaccines in Pittsfield, Mass., on Monday Dec. 13, 2021. Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, May 23, 2022. Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots. (Ben Garver/The Berkshire Eagle via AP, File)

AP
premium content - for subscribers only
Click to subscribe

Pfizer says 3 COVID shots protect children under 5
By LAURAN NEERGAARD - AP Medical Writer
Mon,05/23/22-5:46AM , 212 Reads
Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday, another step toward shots for the littlest kids possibly beginning in early summer.
Click Here to Read More

Subscribe to LAURAN NEERGAARD